Airwheel at Canton Fair 2026: Discover AI-Powered Luxury Rideable Electric 20inch Cabin Boarding Travel Smart Carry on Hand Suitcase
Avantor Expands RIM Single-Use Portfolio Across APAC
HKTDC backs new blueprint for Hong Kong’s next chapter
GA-ASI Mojave First UAS To Complete Battlefield Short Field Ops
Critical Minerals Minister Officially Opens GMG’s Gen 2.0 Graphene Manufacturing Plant
KBP-5074, a highly-selective non-steroidal mineralocorticoid receptor antagonist, lowered clinic systolic blood pressure (SBP) by 10.2…
SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced activation of…
Supporting data in preclinical model of drug-resistant epilepsy demonstrate seizure-freedom in 70% of the NRTX-1001…
WATERTOWN, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
TORONTO, June 16, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
-Study to be conducted at multiple sites across Europe through European Network of Gynaecological Oncological Trial…
Nes Ziona, Israel, June 16, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
SEATTLE, June 16, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, a late-stage biopharmaceutical company focused on…
– NDA Filed by U.S. Food and Drug Administration (FDA) and given Priority Review for…
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
FORT LAUDERDALE, Fla., June 16, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
37% CR rate in 30 efficacy-evaluable patients BOSTON, June 16, 2021 (GLOBE NEWSWIRE) — Aprea…
SAN FRANCISCO and SUZHOU, China, June 16, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq:…
Expanded A.I. and machine learning capabilities will accelerate Mydecine’s broader research and development efforts DENVER,…
AUSTIN, Texas, June 16, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
— U.S.-Based Sites Ready to Begin Enrolling Patients, Placebo-Controlled Study Evaluating NUZYRA Efficacy at 12…
Zai Lab granted combination of regional Asian and global rights for up to four CD3-…
MALVERN, Pa., June 16, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…